Main Article Content
Aims: To propose a primary nutritional recommendation for patients in the early stage of SLE to contribute to a better quality of life for those affected by the disease.
Methodology: This is a theoretical study, with no direct approach or intervention to any patient. The research was carried out using a conceptual approach based on a narrative and explanatory literature review. The main key descriptors of health were: Lupus and skin lesions; butterfly wing or arthritis, nutrition and lupus. After that, a diet (with a menu) for primary nutritional guidance to patients with early symptoms was followed.
Results: The scientific literature evaluates that Systemic Lupus Erythematosus (SLE) is a chronic, autoimmune inflammatory disease, with no cure, which can have multiple causes (hormonal, infectious, genetic and environmental). The production of autoantibodies in tissues, generated from recognized apoptotic fragments, processed and associated with the Principal Human Histocompatibility Complex are also characteristic of SLE. In addition, SLE is mainly characterized by the involvement of the skin, joints, kidneys and serous membranes. The symptoms of SLE vary according to the stage of the disease, affecting different organs, tissues and, in more severe cases, the central and peripheral nervous system. The incidence of SLE is about ten times higher in females and affects more commonly Afro-American, Hispanic and Asian people. In addition, the individual's eating habits and nutritional status can influence the intensity and worsening of symptoms. Regarding nutritional guidance, it is of utmost importance to have anti-inflammatory and antioxidant substances in the diet, avoiding the exaggeration of bad fats, refined carbohydrates, and proteins.
Conclusion: SLE patients should receive a multidisciplinary therapeutic approach, including follow-up by a nutritionist, who will prioritize the maintenance of the patient's adequate weight, avoiding overloading of his joints. This will contribute for a better quality of life for those affected.
Augusto RDB. Influence of gender on the development of autoimmune diseases. Portugal. Dissertation. (Integrated Master in Medicine) - University of Porto, Portugal; 2013.
Fonseca SB. Systemic lupus erythematosus: causes, pathological mechanisms and future therapeutic targets. (Integrated Master in Medicine) - University of Porto, Portugal; 2009.
Borba EF, Latorre LC, Brenol JC, Kayser C, Silva NA, Zimmermann AF et al. Consensus of systemic lupus erythematosus. Rev Bras Reumatol. 2008; 48(4):196-207.
Queiroz ACM, Kosminsky S. Epstein-Barr virus infection in patients with systemic lupus erythematosus. Rev. Assoc.Med. Bras. 2006;52(5):352-355.
Abbas AK, Licthman AH, Pillai S. Cellular and molecular immunology. 7 ed. Rio de Janeiro: Elsevier; 2011.
Brazil. Ministry of Health. Ordinance SAS/ MS nº 100, approves the Clinical Protocol and Therapeutic Guidelines for Systemic Lupus Erythematosus. Federal Official Gazette; 2013.
Borba Neto EF, Reis Neto ET, Shinjo SK, Watanabe SH. Systemic lupus erythematosus, from the bench to the office. Revista Paulista Reumatologia 2017;16(2):5.
Dutschmann L. Systemic lupus erythematosus: Some historical aspects. Points of View - Internal Med. 2066;13(2): 133-140.
Zimmermann, Adriana Fonte. Systemic lupus erythematosus: Demographic, clinical and autoimmune profile of 90 patients in southern Brazil. Dissertation. (Post-Graduation in Internal Medicine), Federal University of Paraná; 1997.
Vargas KS, Romano, MA. Systemic lupus erythematosus: Epidemiological aspects and diagnosis. Salus Magazine. 2009;3 (1):79-94.
Costi LT, Iwamoto HM, Neves DCO, Caldas CAM. Mortality from systemic lupus erythematosus in Brazil: Assessment of causes according to the government's health database. Rev. Bras. Reumatol. 2017;57(6):574-582.
Pasoto SG, Bonfá ESO. Auto antibodies in SLE: from pathogenesis to its importance in clinical practice. Revista Paulista Reumatologia. 2017;16(2):6-13.
Clinical Protocol and Therapeutic Guidelines. Systemic lupus erythematosus Ordinance SAS/MS nº 100; 2013.
[Accessed on March 15, 2020].
Caznoch, CJ, Esmanhotto L, Silva, MB, Shakre, TL. Pattern of joint involvement in patients with systemic lupus erythematosus and its association with the presence of rheumatoid factor and hyperelasticity. Rev. Bras. Reumatol. 2006;46(4):261-265.
Snows AM. Systemic lupus erythematosus (SLE) (disseminated lupus erythematosus or lupus). MSD Manual version for family health.
[Accessed 16 March 2020]
Available:at:https://www.msdmanuals.com/pt/casa/dist%C3%BArbios-%C3%B3sseos,-articulares-e-musculares/doen%C3%A7as-autoimunes-do-tecido-conjuntivo/l % C3% BApus-erythematosus-system% C3% AAmico-les.
Brazilian Society of Rheumatology. What is Systemic Lupus Erythematosus (SLE).
[Accessed 12 March 2020]
Lupus Foundation of America. What causes Lupus?
[Accessed 15 May 2020]
Bartels C, Muller D. Systemic lupus erithematosus (SLE). 2020;1-48.
Lima PS, Carvalho, DMB, Leitão JMSR, Costa CLSC, Moura HN, et al. Systemic lupus erythematosus and its disease process: A female conception. Revista Eletrônica Saúde. 2018;18:e115.
LPC insurance, BorbaNeto EF. Lupus nephritis: Treatment based on consensus and refractory cases. Revista Paulista Reumatologia. 2017;16(2):14-28.
Brazil. Ministry of Health. Lupus: causes, symptoms, diagnosis, treatment and prevention.
Falcão CA, et al. Lupus Carditis. Arq Bras Cardiol. 2000;74(1):63-71.
Mocarzel LOC, et al. Systemic Lupus Erythematosus: Review of cardiovascular manifestations. [Internet]. Universidade Federal Fluminense - Antônio Pedro University Hospital. Rio Janeiro, Brazil; 2015.
Appenzeller S. The central nervous system in Systemic Lupus Erythematosus: Clinical and magnetic resonance analyzes. State University of Campinas/SP; 2006.
Systemic Lupus International Collaborating Clinics - SLICC. (homepage on the Internet]; 2012.
Brazilian Society of Rheumatology. Treatment of Systemic Lupus Erythematosus.
[Accessed 12 March 2020]
Almeida IJGV, Almeida BLF, Souza TA. Severe systemic lupus erythematosus: Case report. Themes in Health. 2018;18 (2):177-185.
Szekanecz Z, Koch, AE. Vascular involvement in rheumatic diseases: ‘vascular rheumatology’. Arthritis Research & Therapy. 2008;10(5):224.
Miller ML, Magilavy DB, Warren RW. The immunologic basis of lupus. Pediatr Clin North Am; 1986.
Souza VA, Bastos MG, Fernandes NM, Mansur HN, Raposo NR, Souza DM, Andrade LC1. Association of hypovitaminosis D with Systemic Lupus Erythematosus and inflammation. J Bras Nefrol. 2014;36(4):430-436.
Meydani SN, Lipman R, Blumberg JB, Taylor A. Dietary Energy restriction decreases ex vivo spleen prostaglandin E2 synthesis in Emory mice. J Nutr. 1990;120 (1):112-5.
Klack K, Bonfa E, BorbaNeto EF. Diet and nutritional aspects in Systemic Lupus Erythematosus. Rev. Bras. Reumatol. 2012;52(3):384-408.
Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJA, et al. Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010;212(1):252-259.
Sales C, Oliviero F, Spinella P. Ruolodegliacidigrassi omega-3 nelladietadeipzientiaffeti da patologie reumatiche infiammatorie. Reumatismo. 2008;60(2):95-101.
Cleland LG, James MJ, Proudman, SM. Fish oil: What the prescriber needs to know. Therapy. 2006;8:202.
Brown AC. Lupus erythematosus and nutrition: A review of the literature. J Renal Nut. 2000;110(4):170-183.
Moreira APB, Alfenas RCGA, Sant'Ana LFR, Priore SE, Franceschini SCCE. Evolution and interpretation of dietary recommendations for macronutrients. Rev. Bras. Nutr. Clin. 2012;27(1):51-9.
Gracanin AG, Marković I, Loncarević J, Golob M, Morović-Vergles J. Bone mineral density in patients with systemic lupus erythematosus - our results Rheumatize. 2015;62(2):16-21.
Tsoh TK, Huang W-Nan. Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic Lupus erythematosus. Rheumatol Int. 2008.
James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR, et al. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus. 2007;16: 401–409.